Cargando…
A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery
BACKGROUND: Predicting treatment response or survival of cancer patients remains challenging in immuno-oncology. Efforts to overcome these challenges focus, among others, on the discovery of new biomarkers. Despite advances in cellular and molecular approaches, only a limited number of candidate bio...
Autores principales: | Creemers, Jeroen H A, Lesterhuis, W Joost, Mehra, Niven, Gerritsen, Winald R, Figdor, Carl G, de Vries, I Jolanda M, Textor, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169479/ https://www.ncbi.nlm.nih.gov/pubmed/34059522 http://dx.doi.org/10.1136/jitc-2020-002032 |
Ejemplares similares
-
Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome
por: Gorris, Mark A J, et al.
Publicado: (2022) -
Discovery and validation of surface N-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets
por: Oldham, Robyn A A, et al.
Publicado: (2020) -
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome
por: Creemers, Jeroen H. A., et al.
Publicado: (2023) -
T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy
por: Stephen, Bettzy, et al.
Publicado: (2023) -
KALRN mutations promote antitumor immunity and immunotherapy response in cancer
por: Li, Mengyuan, et al.
Publicado: (2020)